[关键词]
[摘要]
目的:评估全身炎症反应和高凝状态在糖尿病视网膜病变(DR)及其威胁视力的并发症\〖糖尿病性黄斑水肿(DME)和新生血管性青光眼(NVG)\〗发病机制中的临床意义,并探讨常规及新型血液学指标对DR早期检出与风险分层的诊断效能。
方法:本研究为横断面研究,收集于我院行体格检查的DR患者及健康对照者。所有参与者均接受外周血常规检测。计算并比较两组间常规血液学参数及新型复合指标,包括平均血小板体积/淋巴细胞计数(PMLR)和平均血小板体积×中性粒细胞计数/淋巴细胞计数(PMNLR)。在DR队列中进行亚组分析,比较单纯DR患者与合并DME或NVG的患者。采用Logistic回归分析与DR及其并发症相关的危险因素。应用受试者工作特征(ROC)曲线评估单一及联合血液学标志物的诊断效能,并计算最佳截断值、敏感度、特异度、曲线下面积(AUC)及95%置信区间(CI)。
结果:共纳入497例DR患者(男243例,女254例,平均年龄58.01±11.13岁)和858例健康对照者(男473例,女385例,平均年龄58.05±12.14岁)。与健康组相比,DR组白细胞计数、中性粒细胞计数(NEU)、中性粒细胞与淋巴细胞比值(NLR)及全身免疫炎症指数(SII)显著升高,血小板计数显著降低,而平均血小板体积升高(均P<0.05)。在DR患者中,不同亚组的炎症及血小板相关指标存在差异:DME组NEU、NLR及PMNLR高于单纯DR组,NVG组NEU、NLR、SII及PMNLR高于单纯DR组(均P<0.05),提示不同DR并发症具有不同的血液学特征。多因素Logistic回归显示NEU、单核细胞计数(MONO)、PMLR及SII是DR发生的危险因素(均OR>1),淋巴细胞计数(LYM)是DR发生的保护因素(OR=0.326)。ROC曲线分析显示,NLR、NEU和PMNLR对DR诊断具有较好的敏感度和特异度,联合多标志物模型(NLR+NEU+PMNLR)可获得更高的诊断准确性(AUC=0.743,95%CI:0.716-0.770)。
结论:炎症反应和高凝状态在DR及其并发症的发生发展中发挥关键作用。NLR、NEU、SII、PMLR和PMNLR等血液标志物可作为DR早期诊断和风险分层的有效工具。未来研究应聚焦于疾病进展过程中上述标志物的纵向监测,并通过多中心研究在不同人群中验证其临床应用价值。
[Key word]
[Abstract]
AIM: To evaluate the clinical significance of systemic inflammatory responses and hypercoagulability in the pathogenesis of diabetic retinopathy(DR)and its vision-threatening complications including diabetic macular edema(DME)and neovascular glaucoma(NVG), and to explore the diagnostic efficacy of routine and novel hematological indices for early DR detection and risk stratification.
METHODS:DR patients and healthy control participants who underwent physical examinations in our hospital were enrolled in this cross-sectional study. All participants underwent routine peripheral blood tests. Conventional hematological parameters and novel composite indices, including mean platelet volume-to-lymphocyte count ratio(PMLR)and mean platelet volume×neutrophil count/lymphocyte count(PMNLR), were calculated and compared between groups. Subgroup analyses were conducted within the DR cohort to compare patients with uncomplicated DR versus those with DME or NVG. Logistic regression analysis was used to identify risk factors associated with DR and its complications. Receiver operating characteristic(ROC)curves were applied to evaluate the diagnostic efficacy of single and combined hematological markers, with optimal cut-off values, sensitivity, specificity, area under the curve(AUC)and 95% confidence interval(CI)calculated.
RESULTS: A total of 497 DR patients(243 males and 254 females; mean age 58.01±11.13 y)and 858 healthy controls(473 males and 385 females; mean age 58.05±12.14 y)were enrolled. The DR group exhibited significantly higher levels of white blood cell count, neutrophil count(NEU), neutrophil-to-lymphocyte ratio(NLR), and systemic immune-inflammation index(SII), and mean platelet volume, along with significantly lower platelet counts, compared to the healthy group(all P<0.05). Among DR patients, hematological profiles differed across subgroups: the DME group had higher NEU, NLR, and PMNLR than the simple DR group, while the NVG group had higher NEU, NLR, SII, and PMNLR than the simple DR group(all P<0.05), suggesting distinct hematological profiles among DR subgroups. Multivariate logistic regression showed that NEU, monocyte count(MONO), PMLR, and SII were risk factors for DR(all OR >1)and lymphocyte count(LYM)was protective factor for DR(OR=0.326). ROC curve analysis revealed that NLR, NEU, and PMNLR exhibited favorable sensitivity and specificity for DR diagnosis, with a combined multi-marker model(NLR+NEU+PMNLR)yielding improved diagnostic accuracy(AUC=0.743, 95%CI: 0.716-0.770).
CONCLUSION:Inflammation and hypercoagulability play critical roles in the development of DR and its complications. Blood markers such as NLR, NEU, SII, PMLR, and PMNLR may serve as valuable tools for early diagnosis and risk stratification of DR. Future research should focus on longitudinal monitoring of these markers during disease progression and validate their clinical utility across diverse populations through multi-center studies.
[中图分类号]
[基金项目]
山西省卫生健康委科研课题引导性科技专项(No.2025YD056); 山西省眼科医院青年科学基金(No.C202301)